Activin and Inhibin

EHMT2-IN-1 is a potent EHMT inhibitor, with IC 50 s of all &lt:100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disorder or cancerIn VitroEHMT2-IN-1 (Compound 108) potent EHMT inhibitor, with IC 50 s of all

EHMT2-IN-2 is a potent EHMT inhibitor, with IC 50 s of all &lt:100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disease or cancerIn VitroEHMT2-IN-2 (Compound 200) is a potent EHMT inhibitor, with IC 50 s of

EHMT2-IN-2 is a potent EHMT inhibitor, with IC 50 s of all &lt:100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disease or cancerIn VitroEHMT2-IN-2 (Compound 200) is a potent EHMT inhibitor, with IC 50 s of

EHMT2-IN-2 is a potent EHMT inhibitor, with IC 50 s of all &lt:100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disease or cancerIn VitroEHMT2-IN-2 (Compound 200) is a potent EHMT inhibitor, with IC 50 s of

EHMT2-IN-2 is a potent EHMT inhibitor, with IC 50 s of all &lt:100 nM for EHMT1 peptide, EHMT2 peptide and cellular EHMT2. Used in the research of blood disease or cancerIn VitroEHMT2-IN-2 (Compound 200) is a potent EHMT inhibitor, with IC 50 s of

EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2 . EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus ( LCMV ). EIDD-2749 is a

EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2 . EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus ( LCMV ). EIDD-2749 is a

EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2 . EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus ( LCMV ). EIDD-2749 is a

eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor ( IC 50 =0.26 μM: K d =0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD)

eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor ( IC 50 =0.26 μM: K d =0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD)

eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor ( IC 50 =0.26 μM: K d =0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD)

eIF4A3-IN-1 (compound 53a) is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor ( IC 50 =0.26 μM: K d =0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD)